Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.360
-0.070 (-1.58%)
At close: Aug 15, 2025, 4:00 PM
4.440
+0.080 (1.83%)
After-hours: Aug 15, 2025, 7:25 PM EDT
Vanda Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts that cover Vanda Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $16.5, which forecasts a 278.44% increase in the stock price over the next year. The lowest target is $13 and the highest is $20.
Price Target: $16.5 (+278.44%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 14, 2025.
Analyst Ratings
The average analyst rating for Vanda Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $13 | Buy | Initiates | $13 | +198.17% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +358.72% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +358.72% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +358.72% | Feb 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +312.84% | Feb 4, 2025 |
Financial Forecast
Revenue This Year
232.28M
from 198.77M
Increased by 16.86%
Revenue Next Year
324.68M
from 232.28M
Increased by 39.78%
EPS This Year
-1.52
from -0.33
EPS Next Year
-0.39
from -1.52
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 239.5M | 365.9M | 384.9M |
| Avg | 232.3M | 324.7M | 373.9M |
| Low | 222.5M | 280.8M | 359.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 20.5% | 57.5% | 18.6% |
| Avg | 16.9% | 39.8% | 15.2% |
| Low | 11.9% | 20.9% | 10.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.45 | 0.07 | -0.03 |
| Avg | -1.52 | -0.39 | -0.03 |
| Low | -1.52 | -1.23 | -0.03 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.